Abstract
We draw attention to a number of important considerations in the arguments about screening and outcome of intervention in children with autism and other developmental disorders. Autism screening in itself never provides a final clinical diagnosis, but may well identify developmental deviations indicative of autism—or of other developmental disorders—that should lead to referral for further clinical assessment. Decisions regarding population or clinic screening cannot be allowed to be based on the fact that prospective longitudinal RCT designs over decades could never be performed in complex developmental disorders. We propose an alternative approach. Early screening for autism and other developmental disorders is likely to be of high societal importance and should be promoted and rigorously evaluated.
References
Allaby, M., & Sharma, M. (2011). Screening for Autism Spectrum Disorders in Children below the age of 5 years. A draft report for the UK National Screening Committee. Solutions for Public Health.
Gillberg, C. (2010). The ESSENCE in child psychiatry: Early symptomatic syndromes eliciting neurodevelopmental clinical examinations. Research in Developmental Disabilities, 31, 1543–1551.
Graham, H. K. (2007). The trials of trials. Developmental Medicine and Child Neurology, 49, 163.
Johnson, C. P., & Myers, S. M. (2007). American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics, 120, 1183–1215.
Mesibov, G. B., & Shea, V. (2011). Evidence-based practices and autism. Autism, 15, 114–133. (Review).
Olds, D., Henderson, C. R, Jr, Cole, R., Eckenrode, J., Kitzman, H., Luckey, D., et al. (1998). Long-term effects of nurse home visitation on children’s criminal and antisocial behavior: 15-year follow-up of a randomized controlled trial. JAMA, 280, 1238–1244.
Reichow, B., Barton, E. E., Boyd, B. A., & Hume, K. (2012). Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Systematic Review, 10, CD009260.
Rosenbaum, P. (2010). The randomized controlled trial: An excellent design, but can it address the big questions in neurodisability? Developmental Medicine and Child Neurology, 52, 111.
Weijer, C., Grimshaw, J. M., Eccles, M. P., McRae, A. D., White, A., Brehaut, J. C., et al. (2012). Ottawa ethics of cluster randomized trials consensus group. The Ottawa statement on the ethical design and conduct of cluster randomized trials. PLoS Medicine, 9(11), e1001346.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernell, E., Wilson, P., Hadjikhani, N. et al. Screening, Intervention and Outcome in Autism and Other Developmental Disorders: The Role of Randomized Controlled Trials. J Autism Dev Disord 44, 2074–2076 (2014). https://doi.org/10.1007/s10803-014-2070-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-014-2070-5